Alzchem rises as investors expect higher margin, revenues, analyst says

AlzChem AG

02/03/2026 12:22

** Shares in German specialty chemicals producer Alzchem Group ACT1.DE rise 5.2% as investors expect higher margin and revenue in the future

** Alzchem is a chemical company in Germany that avoided profit warnings as management decided to shift from low‑margin base chemicals to higher‑margin specialty products, Peter Thilo Hasler from Sphene Capital says

** EBITDA margin in 2025 was 20.7% from 12.5% on average between 2016 and 2022, Hasler points out

** Besides, "capacity expansions have the potential to increase consolidated sales to over EUR 1 billion before the end of this decade," the analyst adds

** The stock is the top performer of German small-cap index .SDAXI

** Alzchem rises despite investors' fears over the impact of the U.S.-Iran conflict on European chemical peers, which slide in morning trade

(Reporting by Amir Orusov)

((Amir.orusov@thomsonreuters.com))